BSECompany UpdateMgmt Change24 Sept 2026
LINCOLN PHARMACEUTICALS LIMITED
LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Lincoln Pharmaceuticals Limited has informed BSE about the cessation of Sr. General Manager - XBRL.
BSECompany UpdateMgmt Change24 Sept 2026
LINCOLN PHARMACEUTICALS LIMITED
LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Lincoln Pharmaceuticals Limited has informed BSE about the appointment of a Sr. General Manager - XBRL.
BSECompany UpdateMgmt Change24 Sept 2026
LINCOLN PHARMACEUTICALS LIMITED
LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Lincoln Pharmaceuticals Limited has informed BSE about the appointment of a new Sr. General Manager - XBRL.
BSECompany UpdateMgmt Change24 Sept 2026
LINCOLN PHARMACEUTICALS LIMITED
LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Lincoln Pharmaceuticals Limited has informed BSE about the cessation of Sr. General Manager - XBRL.
BSECompany UpdateMgmt Change24 Sept 2026
LINCOLN PHARMACEUTICALS LIMITED
LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Lincoln Pharmaceuticals Limited has informed BSE about the cessation of Sr. General Manager. The details are not provided.
BSECompany UpdateMgmt Change24 Sept 2026
LINCOLN PHARMACEUTICALS LIMITED
LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Lincoln Pharmaceuticals Limited has announced the appointment of a new Senior General Manager.
BSECompany UpdateMgmt Change24 Sept 2026
LINCOLN PHARMACEUTICALS LIMITED
LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Lincoln Pharmaceuticals Limited has informed the exchange about the cessation of Sr. General Manager - XBRL.
BSECompany Update24 Sept 2026
LINCOLN PHARMACEUTICALS LIMITED
LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Lincoln Pharmaceuticals Limited has informed the BSE about the appointment of a Sr. General Manager. This is a routine update and does not have a significant impact on the company's financials or operations.
BSECompany UpdateMgmt Change24 Sept 2026
LINCOLN PHARMACEUTICALS LIMITED
LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Lincoln Pharmaceuticals Limited has informed the exchange about the cessation of Sr. General Manager - XBRL.
BSECompany UpdateMgmt Change24 Sept 2026
LINCOLN PHARMACEUTICALS LIMITED
LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Lincoln Pharmaceuticals Limited has announced the appointment of a new Senior General Manager.
BSECompany UpdateMgmt Change24 Sept 2026
LINCOLN PHARMACEUTICALS LIMITED
LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Lincoln Pharmaceuticals Limited has informed the exchange about the cessation of Sr. General Manager - XBRL.
BSECompany UpdateMgmt Change24 Sept 2026
LINCOLN PHARMACEUTICALS LIMITED
LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Lincoln Pharmaceuticals Limited has informed BSE about the appointment of a Sr. General Manager, details of which are not provided.
BSEAGM/EGMResults24 Sept 2026
Federal-Mogul Goetze (India) Ltd
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find attached herewith the proceedings of 71st AGM of the Company held on 24th September 2026 through video conferencing.
Federal-Mogul Goetze (India) Ltd held its 71st AGM on September 24, 2026, through video conferencing. The meeting was attended by the Chairman, Directors, CEO, Statutory Auditors, and Secretarial Auditor. The business transacted included adoption of audited financial statements, re-appointment of Directors, and ratification of remuneration payable to the Cost Auditor.
BSEInsider Trading / SASTResults24 Sept 2026
Faze Three Ltd-$
Please refer the attached intimation of Closure of Trading Window for the Quarter ended September 30, 2026.
Faze Three Ltd has announced the closure of its trading window for the quarter ended September 30, 2026, due to the upcoming meeting of the Board of Directors to consider the un-audited financial results for the second quarter.
BSEInsider Trading / SASTResults24 Sept 2026
Coal India Ltd
Trading Window Closure
Coal India Ltd has announced the closure of its trading window from October 1st, 2026, until 48 hours after the declaration of its standalone and consolidated unaudited financial results for the 2nd quarter and half year ended September 30th, 2026.
BSEBoard MeetingMgmt Change24 Sept 2026
Centuple Global Ltd
Outcome of Board Meeting
Centuple Global Ltd has announced the appointment of Mr. Ajay Agarwal as an additional Whole Time Director, subject to approval from members in the ensuing Extra Ordinary General Meeting.
BSEInsider Trading / SAST24 Sept 2026
Spenta International Ltd
Intimation for Closure of Trading Window for the Quarter & Half-year ending on 30th September, 2026
Spenta International Ltd has announced the closure of its trading window for all designated persons from October 1, 2026, until 48 hours after the declaration of un-audited financial results for the quarter and half-year ending September 30, 2026.
BSEInsider Trading / SASTResults24 Sept 2026
Vindhya Telelinks Ltd
Closure of Trading Window.
Vindhya Telelinks Ltd has announced the closure of its trading window for designated persons and their immediate relatives, effective from October 1, 2026, until 48 hours after the declaration of unaudited standalone and consolidated financial results for the quarter and half year ending on September 30, 2026.
BSEInsider Trading / SASTResults24 Sept 2026
GHCL Ltd
Intimation for closing of trading window of the Company
GHCL Ltd has closed its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of un-audited financial results for the quarter ended September 30, 2026.
BSECompany UpdateRegulatory24 Sept 2026
Chambal Fertilisers & Chemicals Ltd
Intimation of Credit Rating
Chambal Fertilisers & Chemicals Ltd has announced that CRISIL Ratings Limited has re-affirmed the credit rating for the company's bank loan facilities. The revised ratings are Crisil AA+/Positive for long-term and Crisil A1+ for short-term.